z-logo
open-access-imgOpen Access
RET-mediated glial cell line derived neurotrophic factor signaling inhibits mouse prostate development
Author(s) -
Hyun Jung Park,
Eric C. Bolton
Publication year - 2017
Publication title -
development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.15
H-Index - 36
eISSN - 1477-9129
pISSN - 0950-1991
DOI - 10.1242/dev.145086
Subject(s) - biology , glial cell line derived neurotrophic factor , neurotrophic factors , ciliary neurotrophic factor , gdnf family of ligands , microbiology and biotechnology , transcription factor , cancer research , signal transduction , cell culture , neuroscience , genetics , receptor , gene
In humans and rodents, the prostate gland develops from the embryonic urogenital sinus (UGS). The androgen receptor (AR) is thought to control the expression of morphogenetic genes in inductive UGS mesenchyme, which promotes proliferation and cytodifferentiation of the prostatic epithelium. However, the nature of the AR-regulated morphogenetic genes and the mechanisms whereby AR controls prostate development are not understood. Glial cell line-derived neurotrophic factor (GDNF) binds GDNF family receptor-α1 (GFRα1) and signals through activation of RET tyrosine kinase. Gene disruption studies in mice have revealed essential roles for GDNF signaling in development, however its role in prostate development is unexplored. Here, we establish novel roles of GDNF signaling in mouse prostate development. Utilizing an organ culture system for prostate development and Ret mutant mice, we demonstrate that RET-mediated GDNF signaling in UGS increases proliferation of mesenchyme cells and suppresses androgen-induced proliferation and differentiation of prostate epithelial cells, inhibiting prostate development. We also identify AR as a GDNF-repressed gene and Gdnf and Gfrα1 as androgen-repressed genes in UGS, thus establishing reciprocal regulatory crosstalk between AR and GDNF signaling in prostate development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here